ZYME FY 2024 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$76M+0.4% YoY

Gross Profit

$76M100.0% margin

Operating Income

-$137M-179.7% margin

Net Income

-$123M-160.8% margin

EPS (Diluted)

$-1.62

Cash Flow

Operating Cash Flow

-$110M

Free Cash Flow

-$113M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$463M

Total Liabilities

$124M

Stockholders' Equity

$339M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$76M	+0.4%
Gross Profit	$76M	-$67M	+213.9%
Operating Income	-$137M	-$138M	+0.7%
Net Income	-$123M	-$119M	-3.4%